Risk Factors for Cryptococcal Meningitis Recurrence in Human Immunodeficiency Virus (HIV)-Infected Patients in a Large Chinese Acquired Immune Deficiency Syndrome (AIDS) Treatment Center
Open Access
- 15 December 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 27, e933688-1-e933688-9
Abstract
Background: Cryptococcal meningitis (CM) is one of the most common opportunistic neuroinfections in patients with HIV. Most studies have focused on non-HIV CM and there are only a few studies on HIV CM in China. The purpose of the present study was to evaluate the characteristics and risk factors for CM recurrence in patients infected with HIV in the Chongqing Public Health Treatment Center in China. Material/Methods: From January 2014 to December 2017, all patients with CM aged 18 years or older were enrolled and a case control study was performed to determine the risk factors associated with recurrence of CM. Antimicrobial susceptibility was determined with a fungal drug sensitivity kit and the sequence types (STs) were analyzed with multilocus sequence typing. Results: The incidence of CM in the 5185 HIV-infected patients was 3.5% (179). Follow-up data were available for 82 of the patients for whom complete medical records were available and they were included in the present study. There were 7 STs among 82 Cryptococcus neoformans isolates; ST5 and ST31 were the most prevalent genotypes. Testing showed that C. neoformans had high sensitivity to 5 antifungal drugs and no differences in resistance were observed, even when different STs were tested. Risk factors for recurrence were analyzed in 69 patients, excluding those who died. The results of multivariate analysis showed that only hospital stay was associated with recurrence of CM. Conclusions: Our results indicated that combining education about medication with clinical treatment could help prevent recurrence of CM.Keywords
This publication has 37 references indexed in Scilit:
- Epidemiology of Cryptococcal Meningitis in the US: 1997–2009PLOS ONE, 2013
- Cryptococcal Genotype Influences Immunologic Response and Human Clinical Outcome after MeningitismBio, 2012
- Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitisJournal of Microbiology, Immunology and Infection, 2012
- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and FlucytosineAntimicrobial Agents and Chemotherapy, 2012
- Cryptococcosis in China (1985–2010): Review of Cases from Chinese DatabaseMycopathologia, 2011
- Progress of the National Pediatric Free Antiretroviral Therapy program in ChinaAIDS Care, 2010
- Cryptococcus neoformansStrains and Infection in Apparently Immunocompetent Patients, ChinaEmerging Infectious Diseases, 2008
- Symptomatic Relapse of HIV‐Associated Cryptococcal Meningitis after Initial Fluconazole Monotherapy: The Role of Fluconazole Resistance and Immune ReconstitutionClinical Infectious Diseases, 2006
- Estimation of the Prevalence of Cryptococcal Infection Among Patients Infected with the Human Immunodeficiency Virus in New York CityClinical Infectious Diseases, 1994
- A Controlled Trial of Fluconazole or Amphotericin B to Prevent Relapse of Cryptococcal Meningitis in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992